QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY
申请人:Alpharmagen, LLC
公开号:EP3166940A1
公开(公告)日:2017-05-17
QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY
申请人:Alpharmagen, LLC
公开号:US20170166561A1
公开(公告)日:2017-06-15
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
US9434724B2
申请人:——
公开号:US9434724B2
公开(公告)日:2016-09-06
[EN] QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY<br/>[FR] COMPOSÉS DE QUINUCLIDINE POUR MODULER L'ACTIVITÉ DU RÉCEPTEUR NICOTINIQUE ALPHA7 DE L'ACÉTYLCHOLINE
申请人:ALPHARMAGEN LLC
公开号:WO2016007630A1
公开(公告)日:2016-01-14
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.